| 英文名称 |
中文名称 |
CAS号 |
操作 |
| KX2-391 |
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺 |
897016-82-9 |
详细
|
| Mericitabine (RG-7128) |
(2'R)- 2'-去氧-2'-氟-2'-甲基胞苷 3',5'-双(2-甲基丙酸)酯 |
940908-79-2 |
详细
|
| RuPhos Pd G3 |
甲磺酸(2-二环己基膦基-2',6'-二异丙氧基-1,1'-联苯基)(2-氨基-1,1'-联苯-2-基)钯(II) |
1445085-77-7 |
详细
|
| NS 3623 |
NS 3623 |
343630-41-1 |
详细
|
| Lasmiditan succinate |
琥珀酸拉斯米迪坦 |
439239-92-6 |
详细
|
| STING agonist-1 (G10) |
702662-50-8 |
702662-50-8 |
详细
|
| Tolterodine tartrate |
酒石酸托特罗定 |
124937-52-6 |
详细
|
| GNE-781 |
GNE-781 |
1936422-33-1 |
详细
|
| Pax2 inhibitor EG1 |
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸 2级 |
693241-54-2 |
详细
|
| Paricalcitol |
帕立骨化醇 |
131918-61-1 |
详细
|
| EGFR-IN-7 |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
详细
|
| Piperazine, 1,1'-[ethylidenebis(2,3-dichloro-4,1-phenylene)]bis- (9CI) |
阿立哌唑二聚物杂质前体 |
784135-99-5 |
详细
|
| WM3835 |
化合物WM-3835 |
2229025-70-9 |
详细
|
| N-methyl-2-pyrrolidin-1-yl-ethanamine |
N-甲基-2-吡咯烷-1-基乙胺二盐酸盐 |
32776-22-0 |
详细
|
| BI-D1870 |
BI-D1870 |
501437-28-1 |
详细
|
| CCT245737 |
5-[[4-[[((2R)-2-吗啉基甲基]氨基]-5-(三氟甲基)-2-吡啶基]氨基]-2-吡嗪腈 |
1489389-18-5 |
详细
|
| Aripiprazole Impurity 53 |
阿立哌唑杂质前体 |
519138-48-8 |
详细
|
| AC1903 |
AC1903 |
831234-13-0 |
详细
|
| AZ-3451 |
(S)-2-(6-溴苯并[D][1,3]二氧杂环戊烯-5-基)-N-(4-氰基苯基)-1-(1-环己基乙基)-1H-苯并[D]咪唑-5-甲酰胺 |
2100284-59-9 |
详细
|
| FB23 |
FB23 |
2243736-35-6 |
详细
|
| JH-X-119-01 |
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- |
2227368-54-7 |
详细
|
| Ivabradine Impurity 95 |
伊伐布雷定杂质 |
55171-70-5 |
详细
|
| KB-0742 HCl |
KB-0742 HCL |
2416873-83-9 |
详细
|
| JNJ63576253 HCl |
化合物JNJ63576253 |
2110428-64-1 |
详细
|
| DMU 212 |
3,4,5,4'-四甲氧基二苯乙烯 |
134029-62-2 |
详细
|
| Maxacalcitol |
马沙骨化醇 |
103909-75-7 |
详细
|
| Epinastine |
依匹斯汀碱 |
80012-43-7 |
详细
|
| CID755673 |
2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one |
521937-07-5 |
详细
|
| PSI-6130 |
2'-去氧-2'-氟-2'-C-甲基胞苷 |
817204-33-4 |
详细
|
| Saxagliptin hydrochloride monohydrate |
沙格列汀盐酸盐一水化合物 |
1370409-28-1 |
详细
|
| TAS-116 |
TAS-116 |
1260533-36-5 |
详细
|
| Mavacamten |
玛伐凯泰 |
1642288-47-8 |
详细
|
| E3 ligase Ligand 5 |
1264754-13-3 |
1264754-13-3 |
详细
|
| UT-155 |
UT-155 |
2031161-35-8 |
详细
|
| Vonafexor(PLX007,EYP-001) |
YP001 |
1192171-69-9 |
详细
|
| dCBP-1 |
化合物DCBP-1 |
2484739-25-3 |
详细
|
| UUN44923 |
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- |
2243944-92-3 |
详细
|
| NS5806 |
NS 5806 |
426834-69-7 |
详细
|
| EGFR Inhibitor |
EGFR INHIBITOR |
879127-07-8 |
详细
|
| Travoprost acid |
221246-34-0 |
221246-34-0 |
详细
|
| CWP232228 |
化合物CWP232228 |
1144044-02-9 |
详细
|
| PF-06882961 |
PF-06882961 |
2230198-02-2 |
详细
|
| BRM/BRG1 ATP Inhibitor-1 |
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA |
2270879-17-7 |
详细
|
| STING INHIBITOR-2 |
N-(3-(4-氟苯基磺酰氨基)-4-羟基苯基)-[1,1'-联苯]-4-甲酰胺 |
2249435-90-1 |
详细
|
| GSK 2118436(SB 590885) |
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氢-1-茚酮肟 |
405554-55-4 |
详细
|
| ODM-201 |
达洛鲁胺 |
1297538-32-9 |
详细
|
| OICR-9429 |
OICR-9429 |
1801787-56-3 |
详细
|
| Amcasertib(BBI503) |
AMCASERTIB |
1129403-56-0 |
详细
|
| Pizuglanstat |
化合物PIZUGLANSTAT |
1244967-98-3 |
详细
|
| SR-717 |
SR-717 |
2375421-09-1 |
详细
|
| Ivabradine Impurity 96 |
伊伐布雷定杂质 |
1206230-25-2 |
详细
|
| MUN36378 |
化合物MUN36378 |
2243736-37-8 |
详细
|
| SU14813 |
SU-14813 |
627908-92-3 |
详细
|
| Fadraciclib |
CYC-065 |
1070790-89-4 |
详细
|
| MB-07344 |
((4-(4-羟基-3-异丙基苯甲基)-3,5-二甲基苯氧基)甲基)膦酸 |
852947-39-8 |
详细
|
| Endovion |
ENDOVION |
265646-85-3 |
详细
|
| SU0268 |
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- |
2210228-45-6 |
详细
|
| AG-270 |
3-(1-环己烯-1-基)-6-(4-甲氧基苯基)-2-苯基-5-(2-吡啶基氨基)吡唑[1,5-A]嘧啶-7(4H)-酮 |
2201056-66-6 |
详细
|
| AZD-5305 |
AZD-5305 |
2589531-76-8 |
详细
|
| ApiliMod |
阿吡莫德 |
541550-19-0 |
详细
|
| PF-5274857 |
PF-5274857 |
1373615-35-0 |
详细
|
| UCB9608 |
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺 |
1616413-96-7 |
详细
|
| Astemizole(R43512) |
阿司咪唑 |
68844-77-9 |
详细
|
| EN4 |
化合物EN4 MYC INHIBITOR |
1197824-15-9 |
详细
|
| BC1618 |
化合物BC1618 |
2222094-18-8 |
详细
|
| AT-527 |
AT-527 |
2241337-84-6 |
详细
|
| PHA-665752 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
详细
|
| NVP-BHG 712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
详细
|
| Phthalazinone pyrazole |
Phthalazinone pyrazole |
880487-62-7 |
详细
|
| BNC105 |
BNC105 |
945771-74-4 |
详细
|
| Apilimod mesylate |
阿吡莫德甲磺酸盐 |
870087-36-8 |
详细
|
| NK-252 |
1414963-82-8 |
1414963-82-8 |
详细
|
| FN-1501 |
1429515-59-2 |
1429515-59-2 |
详细
|
| NI-42 |
NI-42 |
1884640-99-6 |
详细
|
| ML417 |
ML417 |
1386162-69-1 |
详细
|
| Sirtinol |
2-[[(2-羟基-1-萘基)亚甲基]氨基]-N-(1-苯基乙基)苯甲酰胺 |
410536-97-9 |
详细
|
| Imidapril HCl |
盐酸咪达普利 |
89396-94-1 |
详细
|
| benzyl 3-aminocyclobutylcarbamate |
3-(2-羟基乙基)哌嗪-1-羧酸叔丁酯 |
1188265-73-7 |
详细
|
| SJB2-043 |
2-苯基萘并[2,3-D]恶唑-4,9-二酮 |
63388-44-3 |
详细
|
| AdipoRon |
阿迪普隆 |
924416-43-3 |
详细
|
| SP-13786 |
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
1448440-52-5 |
详细
|
| NCT-503 |
NCT503 |
1916571-90-8 |
详细
|
| Samatasvir |
ATOLIHZIXHZSBA-BTSKBWHGSA-N |
1312547-19-5 |
详细
|
| BMS-986195 |
BMS-986195 |
1912445-55-6 |
详细
|
| Dynarrestin |
Dynarrestin |
2222768-84-3 |
详细
|
| FB23-2 |
FB23-2 |
2243736-45-8 |
详细
|
| PF-06873600 |
PF-06873600 |
2185857-97-8 |
详细
|
| Iguratimod |
艾拉莫德 |
123663-49-0 |
详细
|
| WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
详细
|
| Saxagliptin hydrate |
沙格列汀一水合物 |
945667-22-1 |
详细
|
| AS602801(BentaMapiMod) |
本塔马莫 |
848344-36-5 |
详细
|
| Ribociclib succinate |
瑞博西尼琥珀酸盐 |
1374639-75-4 |
详细
|
| GNE-317 |
5-[6-(3-甲氧基-3-氧杂环丁基)-7-甲基-4-(4-吗啉基)噻吩并[3,2-d]嘧啶-2-基]-2-嘧啶胺 |
1394076-92-6 |
详细
|
| Sofosbuvir Impurity |
索非布韦杂质 |
1337529-56-2 |
详细
|
| ADX-102 (NS-2) |
REPROXALAP |
916056-79-6 |
详细
|
| (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONIC ACID-GAMMA-LACTONE 3,5-BIS(4-CHLOROBENZOATE) |
(2R,3R,4R,5R)-2-[(4-氯苯甲酰)甲基]-4-氟-5-羟基-4-甲基氧杂环戊烷-3-基4-氯苯甲酸 |
1294481-80-3 |
详细
|
| USL311 |
USL311 |
1373268-67-7 |
详细
|
| BI-749327 |
BI-749327 |
2361241-23-6 |
详细
|
| ML267 |
4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide trifluoroacetate |
1542213-67-1 |
详细
|
| YQ128 |
化合物YQ128 |
2454246-18-3 |
详细
|
| Nifenalol hydrochloride |
硝苯洛尔盐酸盐 |
5704-60-9 |
详细
|